Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The distribution and pathogenic risk of non-9-valent vaccine covered HPV subtypes in cervical lesions.

Cancer medicine - 1 Mar 2022

Ma Mingjun, Zhu Jingfen, Yang Yongbin, Wang Xiaoyun, Jin Yubiao, Zhang Jiawen, Wu Sufang

Abstract excerpt

Human papillomavirus (HPV) infection is the main cause of female precancerous lesions and cervical cancer. The development and application of HPV prophylactic vaccines have been recognized as a major effective intervention for the control of cervical lesions. However, the infection rate and clinical characters of non-9-valent vaccine covered HPV subtypes are still worth studying. In this retrospective study, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alphapapillomavirus
Share to China
Share to Papillomaviridae

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Papillomavirus Infections

Share to Papillomavirus Vaccines

Share to Pregnancy

Share to Uterine Cervical Dysplasia

Share to Uterine Cervical Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 34981653
DOI: 10.1002/cam4.4532
PMCID: PMC8921916

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The distribution and pathogenic risk of non-9-valent vaccine covered HPV subtypes in cervical lesions.PMID 34981653Read ↗

Characterization of HPV subtypes not covered by the nine-valent vaccine in patients with CIN 2-3 and cervical squamous cell carcinoma.Semantic proximity Read ↗

Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease.Semantic proximity Read ↗

Prevalence Characteristics of Non-16/18 Human Papillomavirus in Fujian, China: A 11-year survey of 101621 womenSemantic proximity Read ↗

Prevalence of cervicovaginal human papillomavirus infection and genotypes in the pre-vaccine era in China: A nationwide population-based study.Semantic proximity Read ↗

Current Updates on Cancer-Causing Types of Human Papillomaviruses (HPVs) in East, Southeast, and South AsiaSemantic proximity Read ↗

Prevalence and genotype distribution of human papillomavirus in women with cervical cancer or cervical intraepithelial neoplasia in Henan province, central China.Semantic proximity Read ↗

Human papillomavirus genotype-specific risks for cervical intraepithelial lesions.Semantic proximity Read ↗

Trend of HPV Molecular Epidemiology in the Post-Vaccine Era: A 10-Year Study.Semantic proximity Read ↗

HPV genotypic spectrum in Jilin province, China, where non-vaccine-covered HPV53 and 51 are prevalent, exhibits a bimodal age-specific pattern.Semantic proximity Read ↗

Role of Human Papillomavirus in Various Cancers: Epidemiology, Screening and PreventionSemantic proximity Read ↗

Prevalence, characteristics, and distribution of HPV genotypes in women from Zhejiang Province, 2016-2020.Semantic proximity Read ↗

Prevalence and Genotype Distribution of Human Papillomavirus in Invasive Cervical Cancer, Cervical Intraepithelial Neoplasia, and Asymptomatic Women in Southeast ChinaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.